EDGAR Filing Documents for 0001104659-21-085723

Form CORRESP - Correspondence:

SEC Accession No. 0001104659-21-085723

Filing Date

2021-06-25

Accepted

2021-06-25 16:16:08

Documents

Document Format Files

Seq	Description	Document	Type	Size
1		filename1.htm	CORRESP	12612
2	GRAPHIC	tm2120744d1_corresp-img001.jpg	GRAPHIC	10949
3	GRAPHIC	tm2120744d1_corresp-img002.jpg	GRAPHIC	3305
4	GRAPHIC	tm2120744d1_corresp-img003.jpg	GRAPHIC	4600
	Complete submission text file	0001104659-21-085723.txt		40051

Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053

Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200

Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations